Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Semple

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta|May 22, 1996
Influence of dose on liposome clearance: critical role of blood proteinsC D Oja, S C Semple, A Chonn, et al.
Biochimica Et Biophysica Acta|March 20, 1999
Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomesS K Klimuk, S C Semple, P Scherrer, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particlesB Mui, S G Raney, S C Semple, et al.
American Journal of Ophthalmology|October 15, 1990
Argon laser photocoagulation for advanced retinopathy of prematurityM B Landers, H C Semple, J B Ruben, et al.
The British Journal of Oral & Maxillofacial Surgery|September 14, 2020
Using a patient prompt list to raise concerns in oncology clinics does not necessarily lead to longer consultationsS N Rogers, C Semple, G M Humphris, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1992
Treatment of retinopathy of prematurity with argon laser photocoagulationM B Landers, C A Toth, H C Semple, et al.
Methods in Enzymology|December 14, 1999
Lipid-based formulations of antisense oligonucleotides for systemic delivery applicationsS C Semple, S K Klimuk, T O Harasym, et al.
The Prostate|July 27, 2007
Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancerCarlo Leonetti, Annamaria Biroccio, Carmen D'Angelo, et al.
The Journal of Investigative Dermatology|April 23, 2004
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTLSandra K Klimuk, Hossain M Najar, Sean C Semple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequenceGabriella Zupi, Marco Scarsella, Sean C Semple, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|May 22, 1996
Influence of dose on liposome clearance: critical role of blood proteinsC D Oja, S C Semple, A Chonn, et al.
Biochimica Et Biophysica Acta|March 20, 1999
Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomesS K Klimuk, S C Semple, P Scherrer, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particlesB Mui, S G Raney, S C Semple, et al.
American Journal of Ophthalmology|October 15, 1990
Argon laser photocoagulation for advanced retinopathy of prematurityM B Landers, H C Semple, J B Ruben, et al.
The British Journal of Oral & Maxillofacial Surgery|September 14, 2020
Using a patient prompt list to raise concerns in oncology clinics does not necessarily lead to longer consultationsS N Rogers, C Semple, G M Humphris, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1992
Treatment of retinopathy of prematurity with argon laser photocoagulationM B Landers, C A Toth, H C Semple, et al.
Methods in Enzymology|December 14, 1999
Lipid-based formulations of antisense oligonucleotides for systemic delivery applicationsS C Semple, S K Klimuk, T O Harasym, et al.
The Prostate|July 27, 2007
Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancerCarlo Leonetti, Annamaria Biroccio, Carmen D'Angelo, et al.
The Journal of Investigative Dermatology|April 23, 2004
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTLSandra K Klimuk, Hossain M Najar, Sean C Semple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequenceGabriella Zupi, Marco Scarsella, Sean C Semple, et al.
Pageof 8